| dc.contributor.author |
Singhvi, Gautam |
|
| dc.date.accessioned |
2024-01-10T07:12:56Z |
|
| dc.date.available |
2024-01-10T07:12:56Z |
|
| dc.date.issued |
2017 |
|
| dc.identifier.uri |
https://benthamscience.com/article/86060 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13774 |
|
| dc.description.abstract |
Around 70% of the pipeline drugs and 40% of marketed drugs come under the BCS class of II and IV. Dissolution of these drugs is a major concern for formulation scientists as poorly soluble drugs consequently affects the bioavailavbility, thus reducing the therapeautic efficacy of these drugs |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Bentham Science |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
IVIVC |
en_US |
| dc.subject |
Lipolysis |
en_US |
| dc.subject |
Lipid based drug delivery systems |
en_US |
| dc.subject |
Biopharmaceutical Classification System (BCS) |
en_US |
| dc.subject |
In vitro characterisation |
en_US |
| dc.title |
In vitro Lipolysis: An Indispensable Tool for the Development of IVIVC of Lipid Based Drug Delivery Systems |
en_US |
| dc.type |
Article |
en_US |